As the flagship journal of the American Cancer Society, CA publishes the latest cancer statistics, ACS guidelines, and reviews on the current state of cancer.
Joined January 2009
- Tweets 4,965
- Following 2,419
- Followers 10,722
- Likes 1,450
2,603 Photos and videos
Pinned Tweet
New from @AmericanCancer: Updated #ColorectalCancer screening guidelines reaffirm screening at age 45 for average-risk adults and expand recommendations to include blood-based and at-home options to reduce barriers to screening.
🔗: acsjournals.onlinelibrary.wi…
@OncoAlert #ASCO26
13
28
4,099
🩺 Pancreatic cancer is rising and often detected late, making it one of the deadliest cancers. Progress in screening, treatment, and research underscores the need for equitable, innovative care: acsjournals.onlinelibrary.wi…
@OncoAlert
9
13
790
HR /HER2- metastatic breast cancer is driven by diverse biology & evolving resistance. @DrDebuTripathy et al discuss precision treatment advances through targeted therapies, genomic profiling, & patient-centered decision making.
🔗 acsjournals.onlinelibrary.wi…
@OncoAlert
4
11
563
New Virtual Tumor Board on choroidal melanoma, a rare tumor of the eye with a high rate of metastasis to the liver, includes insight into the patient experience.
Read this multidisciplinary report:
acsjournals.onlinelibrary.wi…
@OncoAlert @TuftsMedicalCtr @DanaFarber
6
8
862
CA: A Cancer Journal for Clinicians is accepting proposals for high-impact Phase III trials that may inform standards of care. Accepted submissions may qualify for rapid review to align with conference proceedings. Learn more: acsjournals.onlinelibrary.wi… @OncoAlert
2
3
410
CA: A Cancer Journal for Clinicians retweeted
Today! 📣 Our Associate Editor @JGladeBender, a leader in AYA oncology, joins a @CancerCare workshop to discuss issues affecting young adults with cancer, including treatment, survivorship, and navigating care.
Learn more about @PedAYAJournal: acsjournals.onlinelibrary.wi…
@OncoAlert
3
5
540
A 2025 @AmericanCancer report on cancer treatment and survivorship statistics estimates that 18.6 million people in the US are living with a history of cancer.
This number is projected to rise to more than 22 million by 2035: acsjournals.onlinelibrary.wi…
@OncoAlert
4
3
675
New review by @yayaxiawu et al on systemic amyloid light‐chain amyloidosis beyond ANDROMEDA trial summarizes diagnostic challenges and therapeutic updates, with an emphasis on practical diagnostic algorithms and evolving response assessment.
acsjournals.onlinelibrary.wi…
@OncoAlert
2
5
572
The number of cancer survivors is rising, and so is the need for focused research. This #CancerSurvivorsMonth, explore our virtual collection on survivorship research, including statistics, care planning, and long-term outcomes.
🔗 acsjournals.onlinelibrary.wi…
@OncoAlert
5
3
565
Cancer research and cycling have something in common: progress comes one mile at a time. 🚴
This July, ACS Chief Scientific Officer @billdahutmd will take on the Pan Ohio Hope Ride to raise funds that support the fight against cancer.
Donate today ⬇️ secure.acsevents.org/site/ST…
103
ICYMI: New Phase 3 study from @ESTRO_RT @EORTC_BCG: Nodal irradiation for breast cancer decreases breast-cancer related mortality but increases non-breast cancer related mortality after 22.2 years in @EORTC trial 22922/10925.
Read the full open report:
acsjournals.onlinelibrary.wi…
1
9
14
1,525
CA: A Cancer Journal for Clinicians retweeted
📢Final 20-year results from the @EORTC 22922/10925 trial, presented @ESTRO_RT & published @CACancerJournal, provide long-term evidence on the impact of IM-MS lymph node irradiation in patients with stage I–III #breastcancer
👉 shorturl.at/ET33w
👉 shorturl.at/tdGTf
2
5
541
Ahead of Dr. Leticia Nogueira’s #ASCO26 session on the link between environment and cancer care, read her @AmericanCancer statistics report on cancer treatment and survivorship, including the impact of extreme weather events.
acsjournals.onlinelibrary.wi…
@OncoAlert
6
7
366
Happening now at #ASCO26, @DrChoueiri presents a poster on PEAK-1 evaluating casdatifan cabozantinib in advanced clear cell RCC.
Dr. Choueiri was co-senior author on this @AUC3 2025 expert consensus review: acsjournals.onlinelibrary.wi…
@OncoAlert
6
9
374
In a poster session this morning at #ASCO26, @neerajaiims presents ANDROMEDA evaluating AZD9750, a novel AR degrader, in metastatic prostate cancer.
He also co-authored this #OpenAccess review on PARP inhibitors: acsjournals.onlinelibrary.wi…
@OncoAlert
5
11
417
CA: A Cancer Journal for Clinicians retweeted
#PedOnc & #AYACancer are in focus at #ASCO26! Tune in to CancerSpeak & hear from the leaders behind @PedAYAJournal, @AmericanCancer’s new open-access journal dedicated to this field.
Feat. EIC Dr. Nirali Shah, @billdahutmd, & @RamalingamMD:
cancerspeak.podbean.com/e/a-…
@OncoAlert
7
8
532
CA: A Cancer Journal for Clinicians retweeted
🔬 Don't miss @PedAYAJournal EB member @CathyEngMD presenting new metastatic colorectal cancer research during the Gastrointestinal Cancer—Colorectal and Anal Poster Session at #ASCO26.
Explore our multidisciplinary Editorial Board:
acsjournals.onlinelibrary.wi…
@OncoAlert
6
8
535
CA: A Cancer Journal for Clinicians retweeted
💜 Stop by Booth #13000 (Man Up to Cancer and @FightCRC) at #ASCO26 to connect w/ @PedAYAJournal Ed Board member Michael Holtz, whose expertise includes patient advocacy, survivorship, and peer support.
Learn more about @PedAYAJournal:
acsjournals.onlinelibrary.wi…
@OncoAlert
7
8
469
CA: A Cancer Journal for Clinicians retweeted
🌟 New papers have been added to the special series from the @AmericanCancer National Lung Cancer Roundtable, shaping the @NLCRTnews strategic plan to reduce lung cancer incidence and mortality.
Just in time for #ASCO26: acsjournals.onlinelibrary.wi…
@OncoAlert @RamalingamMD
6
9
404
See @Dr_R_Kurzrock's poster at #ASCO26 on target-specific therapy for actionable & approved tumor-agnostic biomarkers. Read her #OpenAccess article on the evolving landscape of tissue-agnostic therapies in precision oncology published in CA.
acsjournals.onlinelibrary.wi…
@OncoAlert
8
9
1,040
See CA Associate Editor @KekoaMDPhD present at #ASCO26 for his poster session on Developmental Therapeutics and the ANDROMEDA trial. Familiarize yourself on the contemporary management of prostate cancer in this #OpenAcess review:
acsjournals.onlinelibrary.wi…
@OncoAlert
3
5
389